Pharmacological Insights and Clinical Challenges of Wenxin Keli in Arrhythmia Treatment

Area of Science:

• Pharmacology and Cardiovascular Medicine
• Traditional Chinese Medicine (TCM) Research
• Drug Discovery and Development

Background:

• Cardiac arrhythmias are a major cause of death, with existing drugs having safety concerns.
• Wenxin Keli (WXKL), a TCM formula, presents a potentially safer alternative for arrhythmia treatment.
• Understanding WXKL's mechanisms and clinical efficacy is crucial for its therapeutic integration.

Purpose of the Study:

• To critically synthesize the pharmacological mechanisms of Wenxin Keli (WXKL).
• To evaluate the clinical evidence for WXKL in treating cardiac arrhythmias like atrial fibrillation.
• To analyze challenges and propose future research directions for WXKL.

Main Methods:

• Systematic review and meta-analysis of clinical trials on WXKL for arrhythmias.
• Pharmacological analysis of WXKL's effects on ion channels (INa, ICaL, Ito) and calcium handling.
• Appraisal of translational limitations, formulation variability, quality control, and regulatory pathways.

Main Results:

• WXKL demonstrates antiarrhythmic properties through ion channel modulation and altered calcium handling.
• Clinical studies suggest efficacy for atrial fibrillation and premature ventricular contractions, with a favorable safety profile.
• Significant challenges include formulation variability, quality control, and regulatory hurdles for TCM products.

Conclusions:

• Wenxin Keli (WXKL) shows promise as an antiarrhythmic agent with a potentially better safety profile than conventional drugs.
• Addressing formulation, quality control, and regulatory issues is essential for WXKL's broader clinical adoption.
• A clear research agenda is proposed to bridge evidence gaps and facilitate WXKL's therapeutic use.